88 related articles for article (PubMed ID: 8526179)
1. Immunotherapy with the storage mite lepidoglyphus destructor.
Armentia-Medina A; Tapias JA; Martín JF; Ventas P; Fernández A
Allergol Immunopathol (Madr); 1995; 23(5):211-23. PubMed ID: 8526179
[TBL] [Abstract][Full Text] [Related]
2. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
Ebner H; Neuchrist C; Havelec L; Kraft D
Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunotherapy with Dermatophagoides extract: in vivo and in vitro results of a double-blind placebo-controlled trial.
Fanales-Belasio E; Ciofalo A; Zambetti G; Ansotegui IJ; Scala E; Paganelli R; Filiaci F
Rhinology; 1995 Sep; 33(3):126-31. PubMed ID: 8560161
[TBL] [Abstract][Full Text] [Related]
5. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
[TBL] [Abstract][Full Text] [Related]
6. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
7. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
[TBL] [Abstract][Full Text] [Related]
8. A multicenter trial of specific local nasal immunotherapy.
Motta G; Passali D; De Vincentiis I; Ottaviani A; Maurizi M; Sartoris A; Pallestrini E; Motta S; Salzano FA
Laryngoscope; 2000 Jan; 110(1):132-9. PubMed ID: 10646729
[TBL] [Abstract][Full Text] [Related]
9. [Rush immunotherapy of perennial allergic rhinitis].
Ito K
Arerugi; 1989 Nov; 38(11):1246-54. PubMed ID: 2627159
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
11. [Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy].
Rogala B; Jarzab J; Rymarczyk B; Tłuczykont B
Wiad Lek; 2004; 57(3-4):123-30. PubMed ID: 15307518
[TBL] [Abstract][Full Text] [Related]
12. Mite-specific immunotherapy using allergen and/or bacterial extracts in atopic patients in Brazil.
Guimarães Junqueir de Queirós M; Oliveira Silva DA; Alves R; Fukuhara Chiba H; Soares de Amaral VB; de Almeida KC; Ynoue LH; de Oliveira Resende R; Camargo Sopelete MC; Rodrigues Silva Segundo G; Ferreira de Sousa Moreira P; Sung SJ; Taketomi EA
J Investig Allergol Clin Immunol; 2008; 18(2):84-92. PubMed ID: 18447136
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
[TBL] [Abstract][Full Text] [Related]
14. [Effect of immunotherapy on house dust mite allergen-specific IgG1 and igG4 antibodies in nasal secretion for patients with perennial allergic rhinitis].
Xiao SF; Wang QH
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Dec; 39(12):725-9. PubMed ID: 15813014
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial.
Varney VA; Edwards J; Tabbah K; Brewster H; Mavroleon G; Frew AJ
Clin Exp Allergy; 1997 Aug; 27(8):860-7. PubMed ID: 9291281
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo controlled study of Alpare mite D. pteronyssinus immunotherapy in asthmatic patients.
Franco C; Barbadori S; Freshwater LL; Kordash TR
Allergol Immunopathol (Madr); 1995; 23(2):58-66. PubMed ID: 8526168
[TBL] [Abstract][Full Text] [Related]
18. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
Worm M
Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):355-60. PubMed ID: 17274520
[TBL] [Abstract][Full Text] [Related]
20. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]